Skip to main content
. Author manuscript; available in PMC: 2008 May 12.
Published in final edited form as: Lancet. 2007 Oct 6;370(9594):1230–1239. doi: 10.1016/S0140-6736(07)61539-6

Table 4.

Cause-specific mortality by treatment group

Placebo (29 844·6 person-years)
Zinc (30 791·7 person-years)
HR (95% CI)
Deaths Rate/1000 person-years Deaths Rate/1000 person-years
Congenital defects 4 0·13 5 0·17 1·21 (0·33−4·44)
Injury 16 0·52 9 0·30 0·55 (0·24−1·26)
Diarrhoea or dysentery 130 4·22 108 3·62 0·81 (0·61−1·07)
ALRI 83 2·70 77 2·58 0·90 (0·64−1·26)
Measles 1 0·03 6 0·20 5·81 (0·64−52·7)
Malnutrition 9 0·29 12 0·40 1·29 (0·52−3·22)
Sepsis or infection 4 0·13 4 0·13 0·97 (0·25−3·73)
SIDS 24 0·78 20 0·67 0·81 (0·43−1·52)
Uncertain or missing* 62 2·01 75 2·51 1·17 (0·79−1·74)

HR=hazard ratio. ALRI=acute lower respiratory illness. SIDS=sudden infant death syndrome. Verbal autopsy information was not available for 17 deaths in the placebo group and 15 deaths in the zinc group.

*

Cause of death could not be classified because of uncertainty or missing information on some items in the verbal autopsy.